TABLE 5.
Other outcomes of clinical pharmacy services for TB care management measured at a follow-up time interval within the intensive and continuation phases.
| Outcome | Venkatapraveen et al. (2012) | Karuniawati et al. (2019) | Tanvejsilp et al. (2018) | |||||
|---|---|---|---|---|---|---|---|---|
| No education | Education | No counseling and leaflet | Counseling | Counseling and leaflet | SAT | Home visit | Pharmaceutical care | |
| Knowledge and adherence score | ||||||||
| Baseline | 6.8 | 6.7 | - | - | - | - | - | - |
| First follow-up | 7.93 | 10.72 | - | - | - | - | - | - |
| Second follow-up | 8.84 | 12.27 | - | - | - | - | - | - |
| p-value | <0.0001 | <0.0001 | - | - | - | - | - | - |
| Compliance in taking medication | ||||||||
| Pre | - | - | 40.00% | 36.00% | 44.00% | - | - | - |
| Post | - | - | 24.00% | 56.00% | 84.00% | - | - | - |
| p-value | - | - | 0.537 | 0.029 | 0.003 | - | - | - |
| EQ-5D-3L score | ||||||||
| Start | - | - | - | - | - | 0.738 ± 0.178 | 0.72 ± 0.21 | 0.661 ± 0.206 |
| End | - | - | - | - | - | 0.913 ± 0.13 | 0.905 ± 0.149 | 0.83 ± 0.269 |
| p-value | - | - | - | - | - | <0.001 | <0.001 | 0.021 |
| VAS | ||||||||
| Start | - | - | - | - | - | 66.43± | 61.5% ± 24.06% | 68.46% ± 15.15% |
| End | - | - | - | - | - | 94% ± 7.51% | 91.94% ± 8.39% | 89.92% ± 9.62% |
| p-value | - | - | - | - | - | <0.001 | <0.001 | <0.001 |
SAT, self-administered therapy; EQ-5D-3L, Euro Quality of Life 5 Dimensions 3 Levels; VAS, visual analog scale